EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elucidating the Unconventional Binding Mode of a DNA‐Encoded Library Hit Provides a Blueprint for Sirtuin 6 Inhibitor Development

Weijie You, Alba L Montoya, Srikanta Dana, Raphael M Franzini, Clemens Steegborn iD

ChemMedChem · 2024

DOI: 10.1002/cmdc.202400273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Weijie You und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Bayreuth, Universitaetsstr. 30, 95447, Bayreuth, Germany. Hauptthemen laut MEDLINE: Sirtuins, DNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, University of Utah Synthesis Core Facility.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sirtuin 6 (Sirt6), an NAD + ‐dependent deacylase, has emerged as a promising target for aging‐related diseases and cancer. Advancing the medicinal chemistry of Sirt6 modulators is crucial for the development of chemical probes aimed at unraveling the intricate biological functions of Sirt6 and unlocking its therapeutic potential. A proprietary DNA‐encoded library yielded Sirt6 inhibitor 2‐Pr, displaying remarkable inhibitory activity and isoform‐selectivity, and featuring a chemical structure distinct from reported Sirt6 modulators. In this study, we explore the inhibitory mechanism of 2‐Pr, evaluating the impact of chemical modifications and presenting a crystal structure of the Sirt6/ADP‐ribose/2‐Pr complex. Notably, co‐crystal structure analysis reveals an unexpected and unprecedented binding mode of Sirt6, with 2‐Pr spanning the acyl channel of the enzyme, extending into the acetyl‐lysine binding pocket, and reaching toward the C‐site. This unique binding mode guides potential avenues for developing potent and selective Sirt6 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirtuinsDNAHumansStructure-Activity RelationshipMolecular StructureBinding SitesDose-Response Relationship, DrugEnzyme InhibitorsCrystallography, X-RayModels, MolecularGene LibraryDrug Development

Stichwörter der Autor:innen

Acyl binding pocketCrystal structureDNA-encoded chemical librariesDeacylaseSirt6 inhibition

Substanzen

SirtuinsSIRT6 protein, humanDNAEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Biochemistry, University of Bayreuth, Universitaetsstr. 30, 95447, Bayreuth, Germany.
  • Los Alamos National Laboratory, 87544, Los Alamos, NM, USA.
  • Department of Medicinal Chemistry, Skaggs College of Pharmacy, University of Utah, 30 S 2000 E, Salt Lake City, 84112, UT, USA.
  • Orion Corporation, Espoo, 84112, Southern Finland, Finland.
  • Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USA.

ORCID-Profile: Clemens Steegborn

Förderung

  • NIA NIH HHS
  • University of Utah Synthesis Core Facility

Zitieren

APA

You, W., Montoya, A. L., Dana, S., Franzini, R. M., & Steegborn, C. (2024). Elucidating the Unconventional Binding Mode of a DNA‐Encoded Library Hit Provides a Blueprint for Sirtuin 6 Inhibitor Development. ChemMedChem. https://doi.org/10.1002/cmdc.202400273

Vancouver

You W, Montoya AL, Dana S, Franzini RM, Steegborn C. Elucidating the Unconventional Binding Mode of a DNA‐Encoded Library Hit Provides a Blueprint for Sirtuin 6 Inhibitor Development. ChemMedChem. 2024. doi:10.1002/cmdc.202400273

BibTeX
@article{You2024,
  author = {You, Weijie and Montoya, Alba L and Dana, Srikanta and Franzini, Raphael M and Steegborn, Clemens},
  title = {Elucidating the Unconventional Binding Mode of a DNA‐Encoded Library Hit Provides a Blueprint for Sirtuin 6 Inhibitor Development},
  journal = {ChemMedChem},
  year = {2024},
  doi = {10.1002/cmdc.202400273}
}
Kostenlos starten →